Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Cardiovascular Toxicology
Erschienen in: Cardiovascular Toxicology 4/2019

07.12.2018

Ischemic Preconditioning Efficacy Following Anabolic Steroid Usage: A Clear Difference Between Sedentary and Exercise-Trained Rat Hearts

verfasst von: Zahra Akbari, Mansour Esmailidehaj, Ebrahim Avarand, Mehrdad Shariati, Khalil Pourkhalili

Erschienen in: Cardiovascular Toxicology | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

Previous studies show that anabolic steroids impair innate cardioprotective mechanisms. Here, we investigated the effect of supraphysiological doses of nandrolone on ischemic preconditioning (IPC) as a potent cardioprotective tool against ischemia reperfusion (IR) injury in rat hearts. Male Wistar rats in two experimental settings of sedentary and exercise-trained (60 min/day swimming, 5 days/week, for 8 weeks) were either pretreated with intramuscular injections of arachis oil (Arach, n = 16) as vehicle or nandrolone decanoate (ND, n = 8), 10 mg/kg/week, for 8 weeks. At the end, the hearts were excised and perfused in a Langendorff system. Then, the vehicle-treated hearts subdivided into the IR (30 min of LAD coronary artery occlusion and 120 min reperfusion, n = 8) and IPC (three cycles of 3-min ischemia and 3-min reperfusion before test ischemia, n = 8) groups and nandrolone-treated hearts served as ND + IPC (nandrolone pretreatment before IR and IPC protocols, n = 8) group. Post-ischemic cardiac function and infarct size were assessed. Reperfusion arrhythmias were analyzed using a standard scoring system. In sedentary hearts, ND slightly increased heart-to-body weight ratio and increased baseline cardiac contractile function. In trained hearts, ND markedly increased heart-to-body weight ratio which was also associated with enhanced baseline cardiac function. ND pretreatment enhanced protective effects of IPC in sedentary group; however, abolished these effects in exercise-trained group. The arrhythmia score was not significantly different between nandrolone-treated groups vs. respective preconditioned groups. Our findings show that ND impairs IPC-induced cardioprotection in exercise-trained rat hearts. Cardiac hypertrophy seems to play a crucial role in this response.
Literatur
1.
Hausenloy, D. J., & Yellon, D. M. (2013). Myocardial ischemia-reperfusion injury: A neglected therapeutic target. Journal of Clinical Investigation, 123, 92–100.CrossRefPubMed
2.
Murry, C. E., Jennings, R. B., & Reimer, K. A. (1986). Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation, 74, 1124–1136.CrossRefPubMed
3.
Lai, C. C., Tang, C. Y., Chiang, S. C., Tseng, K. W., & Huang, C. H. (2015). Ischemic preconditioning activates prosurvival kinases and reduces myocardial apoptosis. Journal of the Chinese Medical Association, 78, 460–468.CrossRefPubMed
4.
Iliodromitis, E. K., Lazou, A., & Kremastinos, D. T. (2007). Ischemic preconditioning: Protection against myocardial necrosis and apoptosis. Vascular Health and Risk Management, 3, 629–637.PubMedPubMedCentral
5.
Li, Y. W., Whittaker, P., & Kloner, R. A. (1992). The transient nature of the effect of ischemic preconditioning on myocardial infarct size and ventricular arrhythmia. American Heart Journal, 123, 346–353.CrossRefPubMed
6.
Galagudza, M. M., Sonin, D. L., Vlasov, T. D., Kurapeev, D. I., & Shlyakhto, E. V. (2016). Remote vs. local ischaemic preconditioning in the rat heart: Infarct limitation, suppression of ischaemic arrhythmia and the role of reactive oxygen species. International Journal of Experimental Pathology, 97, 66–74.CrossRefPubMedPubMedCentral
7.
Kersey, R. D., Elliot, D. L., Goldberg, L., Kanayama, G., Leone, J. E., Pavlovich, M., et al. (2012). National athletic trainers’ association position statement: Anabolic–androgenic steroids. Journal of Athletic Training, 47, 567–688.CrossRefPubMedPubMedCentral
8.
Woerdeman, J., & de Ronde, W. (2011). Therapeutic effects of anabolic androgenic steroids on chronic diseases associated with muscle wasting. Expert Opinion on Investigational Drugs, 20, 87–97.CrossRefPubMed
9.
Marqueti, R. C., Micocci, K. C., Leite, R. D., & Selistre-de-Araujo, H. S. (2012). Nandrolone inhibits MMP-2 in the left ventricle of rats. International Journal of Sports Medicine, 33, 181–185.CrossRefPubMed
10.
11.
Pirompol, P., Teekabut, V., Weerachatyanukul, W., Bupha-Intr, T., & Wattanapermpool, J. (2016). Supra-physiological dose of testosterone induces pathological cardiac hypertrophy. Journal of Endocrinology, 229, 13–23.CrossRefPubMed
12.
Ammar, E. M., Said, S. A., & Hassan, M. S. (2004). Enhanced vasoconstriction and reduced vasorelaxation induced by testosterone and nandrolone in hypercholesterolemic rabbits. Pharmacological Research, 50, 253–259.CrossRefPubMed
13.
Nascimento, J. H., & Medei, E. (2011). Cardiac effects of anabolic steroids: Hypertrophy, ischemia and electrical remodelling as potential triggers of sudden death. Mini Reviews in Medicinal Chemistry, 11, 425–429.CrossRefPubMed
14.
Fineschi, V., Riezzo, I., Centini, F., Silingardi, E., Licata, M., Beduschi, G., et al. (2007). Sudden cardiac death during anabolic steroid abuse: Morphologic and toxicologic findings in two fatal cases of bodybuilders. International Journal of Legal Medicine, 121, 48–53.CrossRefPubMed
15.
Du Toit, E. F., Rossouw, E., Van, Rooyen, J., & Lochner, A. (2005). Proposed mechanisms for the anabolic steroid-induced increase in myocardial susceptibility to ischaemia/reperfusion injury. Cardiovascular Journal of South Africa, 16, 21–28.PubMed
16.
Chaves, E. A., Fortunato, R. S., Carvalho, D. P., Nascimento, J. H. M., & Oliveira, M. F. (2013). Exercise-induced cardioprotection is impaired by anabolic steroid treatment through a redox-dependent mechanism. The Journal of Steroid Biochemistry and Molecular Biology, 138, 267–272.CrossRefPubMed
17.
Bissoli, N. S., Medeiros, A. R. S., Santos, M. C. S., Busato, V. C. W., Jarske, R. D., Abreu, G. R., et al. (2009). Long-term treatment with supraphysiological doses of nandrolone decanoate reduces the sensitivity of Bezold–Jarisch reflex control of heart rate and blood pressure. Pharmacological Research, 59, 379–384.CrossRefPubMed
18.
Abdollahi, F., Joukar, S., Najafipour, H., Karimi, A., Masumi, Y., & Binayi, F. (2016). The risk of life-threatening ventricular arrhythmias in presence of high-intensity endurance exercise along with chronic administration of nandrolone decanoate. Steroids, 105, 106–112.CrossRefPubMed
19.
Binayi, F., Joukar, S., Najafipour, H., Karimi, A., Abdollahi, F., & Masumi, Y. (2016). The effects of nandrolone decanoate along with prolonged low-intensity exercise on susceptibility to ventricular arrhythmias. Cardiovascular Toxicology, 16, 23–33.CrossRefPubMed
20.
Penna, C., Abbadessa, G., Mancardi, D., Tullio, F., Piccione, F., Spaccamiglio, A., et al. (2008). Synergistic effects against post-ischemic cardiac dysfunction by sub-chronic nandrolone pretreatment and postconditioning: Role of beta2-adrenoceptor. Journal of Physiology and Pharmacology, 59, 645–659.
21.
Penna, C., Tullio, F., Perrelli, M. G., Moro, F., Abbadessa, G., Piccione, F., et al. (2011). Ischemia/reperfusion injury is increased and cardioprotection by a postconditioning protocol is lost as cardiac hypertrophy develops in nandrolone treated rats. Basic Research in Cardiology, 106, 409–420.CrossRefPubMed
22.
Do Carmo, E. C., Fernandes, T., Koike, D., Da Silva, N. D., Mattos, K. C., Rosa, K. T., et al. (2011). Anabolic steroid associated to physical training induces deleterious cardiac effects. Medicine and Science in Sports and Exercise, 43, 1836–1848.CrossRefPubMed
23.
Pereira-Junior, P. P., Chaves, E. A., Costa, E. S. R. H., Masuda, M. O., de Carvalho, A. C., & Nascimento, J. H. (2006). Cardiac autonomic dysfunction in rats chronically treated with anabolic steroid. European Journal of Applied Physiology, 96, 487–494.CrossRefPubMed
24.
Tanno, A. P., Neves, V. J. d., Rosa, K. T., Cunha, T. S., Giordano, F. C. L., & Calil, C. M. (2011). Nandrolone and resistance training induce heart remodeling: Role of fetal genes and implications for cardiac pathophysiology. Life Sciences, 89, 631–637.CrossRefPubMed
25.
Pope, Jr. H. G., Katz, D. L. (1988). Affective and psychotic symptoms associated with anabolic steroid use. American Journal of Psychiatry, 145, 487–490.CrossRefPubMed
26.
Norton, G. R., Trifunovic, B., Woodiwiss, A. J. (2000). Attenuated beta-adrenoceptor-mediated cardiac contractile responses following androgenic steroid administration to sedentary rats. European Journal of Applied Physiology, 81, 310–316.CrossRefPubMed
27.
28.
Shokri, S., Aitken, R. J., Abdolvahhabi, M., Abolhasani, F., Ghasemi, F. M., Kashani, I., et al. (2009). Exercise and supraphysiological dose of nandrolone deconoate increase apoptosis in spermatogenic cells. Basic and Clinical Pharmacology and Toxicology, 106, 324–330.CrossRefPubMed
29.
Schultz, J. E., Hsu, A. K., & Gross, G. J. (1998). Ischemic preconditioning in the intact rat heart is mediated by delta1- but not mu- or kappa-opioid receptors. Circulation, 97, 1282–1289.CrossRefPubMed
30.
Walker, M. J., Curtis, M. J., Hearse, D. J., Campbell, R. W., Janse, M. J., Yellon, D. M., et al. (1988). The Lambeth Conventions: Guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion. Cardiovascular Research, 22, 447–455.CrossRefPubMed
31.
Song, Y., Song, J. W., Lee, S., Jun, J. H., Kwak, Y. L., & Shim, J. K. (2017). Effects of remote ischemic preconditioning in patients with concentric myocardial hypertrophy: A randomized, controlled trial with molecular insights. International Journal of Cardiology, 249, 36–41.CrossRefPubMed
32.
Seara, F. A. C., Barbosa, R. A. Q., de Oliveira, D. F., Gran da Silva, D. L. S., Carvalho, A. B., Ferreira, A. C. et al. (2017). Administration of anabolic steroid during adolescence induces long-term cardiac hypertrophy and increases susceptibility to ischemia/reperfusion injury in adult Wistar rats. Journal of Steroid Biochem Molecular Biology, 171, 34–42.CrossRef
33.
Beutel, A., Bergamaschi, C. T., & Campos, R. R. (2005). Effects of chronic anabolic steroid treatment on tonic and reflex cardiovascular control in male rats. The Journal of Steroid Biochemistry and Molecular Biology, 93, 43–48.CrossRefPubMed
34.
Rocha, F. L., Carmo, E. C., Roque, F. R., Hashimoto, N. Y., Rossoni, L. V., Frimm, C., et al. (2007). Anabolic steroids induce cardiac renin-angiotensin system and impair the beneficial effects of aerobic training in rats. American Journal of Physiology; Heart Circulation Physiology, 293, H3575–H3583.CrossRef
35.
Lunz, W., Oliveira, E. C., Neves, M. T. D., Fontes, E. P. B., Dias, C. M. G. C., & Natali, A. J. (2006). Anabolic steroid and exercise induced cardiac stress protein (HSP72) in the rat. Brazillian Journal of Medical and Biological Research, 39, 889–893.CrossRef
36.
Woodiwiss, A., Trifunovic, G., Philippides, M., & Norton, G. (2000). Effect of an androgenic steroid on exercise-induced cardiac remodeling in rats. Journal of Applied Physiology, 88, 409–415.CrossRefPubMed
37.
Pergolizzi, B., Carriero, V., Abbadessa, G., Penna, C., Berchialla, P., De Francia, S., et al. (2017). Subchronic nandrolone administration reduces cardiac oxidative markers during restraint stress by modulating protein expression patterns. Molecular Cell Biochemistry, 434, 51–60.CrossRef
38.
Chaves, E. A., Pereira-Junior, P. P., Fortunato, R. S., Masuda, M. O., de Carvalho, A. C., de Carvalho, D. P., et al. (2006). Nandrolone decanoate impairs exercise-induced cardioprotection: Role of antioxidant enzymes. Journals of Steroid Biochemistry Molecular Biology, 99, 223–230.CrossRef
39.
Xiao, J., Xu, T., Li, J., Lv, D., Chen, P., Zhou, Q., et al. (2014). Exercise-induced physiological hypertrophy initiates activation of cardiac progenitor cells. International Journal of Clinical and Experimental Pathology, 7, 663–669.PubMedPubMedCentral
40.
Brasil, G. A., Lima, E. M., Nascimento, A. M., Caliman, I. F., Medeiros, A. R., Silva, M. S., et al. (2015). Nandrolone decanoate induces cardiac and renal remodeling in female rats, without modification in physiological parameters: The role of ANP system. Life Sciences, 137, 65–73.CrossRefPubMed
41.
Iemitsu, M., Miyauchi, T., Maeda, S., Sakai, S., Kobayashi, T., Fujii, N., et al. (2001). Physiological and pathological cardiac hypertrophy induce different molecular phenotypes in the rat. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 281, R2029–R2036.CrossRefPubMed
42.
Molgaard, S., Faricelli, B., Salomonsson, M., Engstrom, T., & Treiman, M. (2016). Increased myocardial vulnerability to ischemia–reperfusion injury in the presence of left ventricular hypertrophy. Journal of Hypertension, 34, 513–523.CrossRefPubMed
43.
Yano, T., Miki, T., Tanno, M., Kuno, A., Itoh, T., Takada, A., et al. (2011). Hypertensive hypertrophied myocardium is vulnerable to infarction and refractory to erythropoietin-induced protection. Hypertension, 57, 110–115.CrossRefPubMed
44.
Snoeckx, L. H., van der Vusse, G. J., van der Veen, F. H., Coumans, W. A., & Reneman, R. S. (1989). Recovery of hypertrophied rat hearts after global ischemia and reperfusion at different perfusion pressures. Pflugers Archiv, 413, 303–312.CrossRefPubMed
45.
Friehs, I., Moran, A. M., Stamm, C., Choi, Y. H., Cowan, D. B., McGowan, F. X., et al. (2004). Promoting angiogenesis protects severely hypertrophied hearts from ischemic injury. The Annals of Thoracic Surgery, 77, 2004–2010.CrossRefPubMed
46.
Chen, C. H., Wu, C. W., Shih, C. D., Lien, W. H., Huang, S. L., & Huang, C. C. (2016). Attenuation of isoflurane preconditioning-induced acute cardioprotection in hypertensive hypertrophied hearts. Journal of Cardiothorac Vascular Anesthesia, 30, 1317–1323.CrossRef
47.
Wagner, C., Ebner, B., Tillack, D., Strasser, R. H., & Weinbrenner, C. (2013). Cardioprotection by ischemic postconditioning is abrogated in hypertrophied myocardium of spontaneously hypertensive rats. Journal of Cardiovascular Pharmacolology, 61, 35–41.CrossRef
48.
Fineschi, V., Di Paolo, M., Neri, M., Bello, S., D’Errico, S., Dinucci, D., et al. (2011). Anabolic steroid- and exercise-induced cardio-depressant cytokines and myocardial beta1 receptor expression in CD1 mice. Current Pharmacology Biotechnology, 12, 275–284.CrossRef
49.
Stelzer, J. E., Brickson, S. L., Locher, M. R., & Moss, R. L. (2007). Role of myosin heavy chain composition in the stretch activation response of rat myocardium. Journal of Physiology, 579, 161–173.CrossRefPubMed
50.
Penna, C., Abbadessa, G., Mancardi, D., Spaccamiglio, A., Racca, S., & Pagliaro, P. (2007). Nandrolone-pretreatment enhances cardiac [beta]2-adrenoceptor expression and reverses heart contractile down-regulation in the post-stress period of acute-stressed rats. The Journal of Steroid Biochemistry and Molecular Biology, 107, 106–113.CrossRefPubMed
51.
das Neves, V. J., Tanno, A. P., Cunha, T. S., Fernandes, T., Guzzoni, V., da Silva, C. A., et al. (2013). Effects of nandrolone and resistance training on the blood pressure, cardiac electrophysiology, and expression of atrial beta-adrenergic receptors. Life Science, 92, 1029–1035.CrossRef
52.
Marques-Neto, S. R., Ferraz, E. B., Rodrigues, D. C., Njaine, B., Rondinelli, E., Campos de Carvalho, A. C., et al. (2014). AT1 and aldosterone receptors blockade prevents the chronic effect of nandrolone on the exercise-induced cardioprotection in perfused rat heart subjected to ischemia and reperfusion. Cardiovascular Drugs Therapy, 28, 125–135.CrossRefPubMed
53.
Zhou, L. Y., Liu, J. P., Wang, K., Gao, J., Ding, S. L., Jiao, J. Q., et al. (2018). Mitochondrial function in cardiac hypertrophy. International Journal of Cardiology, 167, 1118–1125.CrossRef
54.
Abeer, A. M., Noura, H. M., & Maha, Z. M. (2018). The Nandrolone effect on cardiac muscle of adult male albino rat and the possible role of nigella sativa: Light and electron microscopic studies. Journal of Biochemistry and Cell Biology, 1, 109.
55.
Sun, M., Shen, W., Zhong, M., Wu, P., Chen, H., & Lu, A. (2013). Nandrolone attenuates aortic adaptation to exercise in rats. Cardiovascular Research, 97, 686–695.CrossRefPubMed
56.
Hanan, A. E. E., Adel, A. E. A., Mona, A. E. E. S., & Afaf, T. A. (2018). Effect of anabolic steroids on the cardiac and skeletal muscles of adult male rats. International Journal of Clinical and Developmental Anatomy, 4, 1–14.CrossRef
57.
Hassan, N. A., Salem, M. F., & Sayed, M. A. (2009). Doping and effects of anabolic androgenic steroids on the heart: Histological, ultrastructural, and echocardiographic assessment in strength athletes. Human Experimental Toxicology, 28, 273–283.CrossRefPubMed
58.
Achar, S., Rostamian, A., & Narayan, S. M. (2010). Cardiac and metabolic effects of anabolic-androgenic steroid abuse on lipids, blood pressure, left ventricular dimensions, and rhythm. American Journal of Cardiology, 106, 893–901.CrossRefPubMed
59.
Phillis, B. D., Abeywardena, M. Y., Adams, M. J., Kennedy, J. A., & Irvine, R. J. (2007). Nandrolone potentiates arrhythmogenic effects of cardiac ischemia in the rat. Toxicology Science, 99, 605–611.CrossRef
Metadaten
Titel
Ischemic Preconditioning Efficacy Following Anabolic Steroid Usage: A Clear Difference Between Sedentary and Exercise-Trained Rat Hearts
verfasst von
Zahra Akbari
Mansour Esmailidehaj
Ebrahim Avarand
Mehrdad Shariati
Khalil Pourkhalili
Publikationsdatum
07.12.2018
Verlag
Springer US
Erschienen in
Cardiovascular Toxicology / Ausgabe 4/2019
Print ISSN: 1530-7905
Elektronische ISSN: 1559-0259
DOI
https://doi.org/10.1007/s12012-018-9497-4

Weitere Artikel der Ausgabe 4/2019

Cardiovascular Toxicology 4/2019 Zur Ausgabe

OriginalPaper

Acute and Subacute Effects of Low Versus High Doses of Standardized Panax ginseng Extract on the Heart: An Experimental Study

OriginalPaper

SSeCKS/Gravin/AKAP12 Inhibits PKCζ-Mediated Reduction of ERK5 Transactivation to Prevent Endotoxin-Induced Vascular dysfunction

OriginalPaper

Measurement of J–Tpeakc along with QT-Interval Prolongation May Increase the Assay Sensitivity and Specificity for Predicting the Onset of Drug-Induced Torsade de Pointes: Experimental Evidences Based on Proarrhythmia Model Animals

OriginalPaper

Micheliolide Protects Against Doxorubicin-Induced Cardiotoxicity in Mice by Regulating PI3K/Akt/NF-kB Signaling Pathway

OriginalPaper

Linoleic Acid Metabolite DiHOME Decreases Post-ischemic Cardiac Recovery in Murine Hearts

BriefCommunication

Fulminant Vascular and Cardiac Toxicity Associated with Tyrosine Kinase Inhibitor Sorafenib